Cargando…

PET/CT and the Response to Immunotherapy in Lung Cancer

OBJECTIVE: In recent years, the introduction of immune checkpoint inhibitors has significantly changed the outcome of patients affected by lung cancer and cutaneous melanoma. Although the clinical advantages, the selection of patients and the evaluation of response to immunotherapy remain unclear, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evangelista, Laura, Sepulcri, Matteo, Pasello, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206188/ https://www.ncbi.nlm.nih.gov/pubmed/31858908 http://dx.doi.org/10.2174/1874471013666191220105449

Ejemplares similares

Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
por: Sepulcri, Matteo, et al.
Publicado: (2021)

PET/CT in Prostate Cancer
por: Evangelista, Laura, et al.
Publicado: (2023)

Role of radiomic analysis of [(18)F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
por: Marturano, Francesca, et al.
Publicado: (2023)

PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
por: Evangelista, Laura, et al.
Publicado: (2023)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
por: Evangelista, Laura, et al.
Publicado: (2023)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Impact of PET/CT for Assessing Response to Immunotherapy—A Clinical Perspective
por: Lang, David, et al.
Publicado: (2020)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

(18)F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy
por: Feng, Yawen, et al.
Publicado: (2023)

Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview
por: Ferrari, Cristina, et al.
Publicado: (2021)

Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
por: Beuthien-Baumann, Bettina, et al.
Publicado: (2021)

Staging of lung cancer CT and PET
por: McLoud, Theresa C
Publicado: (2014)

The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments
por: Ferro, Alessandra, et al.
Publicado: (2022)

Immunotherapy in malignant pleural mesothelioma: a review of literature data
por: Menis, Jessica, et al.
Publicado: (2021)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review
por: Evangelista, Laura, et al.
Publicado: (2021)

Session: Evaluation of lung nodules: role of PET/CT
por: Bellomi, Massimo, et al.
Publicado: (2014)

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
por: Pavan, A., et al.
Publicado: (2019)

Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT
por: Park, Sohyun, et al.
Publicado: (2020)

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT
por: Niccoli Asabella, Artor, et al.
Publicado: (2021)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer
por: Chen, Zhi‐Yong, et al.
Publicado: (2022)

F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022)

PET/CT imaging in lung cancer: indications and findings
por: Hochhegger, Bruno, et al.
Publicado: (2015)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Lopci, Egesta
Publicado: (2021)

Potentials of Non-Invasive (18)F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
por: Liao, Xuhe, et al.
Publicado: (2022)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis
por: Bauckneht, Matteo, et al.
Publicado: (2020)

Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”
por: Wang, Shan‐Ying, et al.
Publicado: (2022)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

PET/CT and interstitial lung disease
por: Sawamura, Marcio Valente Yamada, et al.
Publicado: (2022)

Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
por: Scagliori, Elena, et al.
Publicado: (2015)

The lung cancers: staging and response, CT, (18)F-FDG PET/CT, MRI, DWI: review and new perspectives
por: Owens, Cara, et al.
Publicado: (2023)

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
por: Urso, Luca, et al.
Publicado: (2023)

PET/CT in the Staging of the Non-Small-Cell Lung Cancer
por: Chao, Fangfang, et al.
Publicado: (2012)

Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation
por: Iovoli, Austin J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5s4ateiu8rq1233rfiubom9rqv